Status:
COMPLETED
Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection
Lead Sponsor:
Fundacion Infant
Conditions:
Covid19
Pregnancy Related
Eligibility:
FEMALE
Brief Summary
This is a multi-center prospective study that aims to investigate the clinical and immunologic impact of SARS-CoV-2 infection in pregnant women and neonates. The goal is to recruit 200 SARS-CoV-2 infe...
Detailed Description
COVID-19, the disease caused by the novel coronavirus SARS-CoV-2, has led to an unprecedented global pandemic affecting persons of all ages. Pregnant women are in a physiologic immunosuppressed situat...
Eligibility Criteria
Inclusion
- Pregnant women hospitalized presenting with:
- Fever with one or more respiratory symptoms (cough, odinophagia, respiratory difficulty)
- Diagnoses of pneumonia with no other explainable cause.
Exclusion
- None
Key Trial Info
Start Date :
July 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT04362956
Start Date
July 10 2020
End Date
October 1 2020
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Italiano
Buenos Aires, Argentina, 1420